Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum CD133-Associated Proteins Identified by Machine Learning Are Connected to Neural Development, Cancer Pathways, and 12-Month Survival in Glioblastoma.
Joyce T, Tasci E, Jagasia S, Shephard J, Chappidi S, Zhuge Y, Zhang L, Cooley Zgela T, Sproull M, Mackey M, Camphausen K, Krauze AV. Joyce T, et al. Among authors: sproull m. Cancers (Basel). 2024 Aug 1;16(15):2740. doi: 10.3390/cancers16152740. Cancers (Basel). 2024. PMID: 39123468 Free PMC article.
MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in Patients with Glioblastoma.
Tasci E, Shah Y, Jagasia S, Zhuge Y, Shephard J, Johnson MO, Elemento O, Joyce T, Chappidi S, Cooley Zgela T, Sproull M, Mackey M, Camphausen K, Krauze AV. Tasci E, et al. Among authors: sproull m. Int J Mol Sci. 2024 Apr 6;25(7):4082. doi: 10.3390/ijms25074082. Int J Mol Sci. 2024. PMID: 38612892 Free PMC article.
Corrigendum: Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel.
Krauze AV, Sierk M, Nguyen T, Chen Q, Yan C, Hu Y, Jiang W, Tasci E, Zgela TC, Sproull M, Mackey M, Shankavaram U, Meerzaman D, Camphausen K. Krauze AV, et al. Among authors: sproull m. Front Oncol. 2024 Mar 13;14:1348105. doi: 10.3389/fonc.2024.1348105. eCollection 2024. Front Oncol. 2024. PMID: 38544831 Free PMC article.
Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation.
Krauze AV, Zhao Y, Li MC, Shih J, Jiang W, Tasci E, Cooley Zgela T, Sproull M, Mackey M, Shankavaram U, Tofilon P, Camphausen K. Krauze AV, et al. Among authors: sproull m. Biomolecules. 2023 Oct 10;13(10):1499. doi: 10.3390/biom13101499. Biomolecules. 2023. PMID: 37892181 Free PMC article.
Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel.
Krauze AV, Sierk M, Nguyen T, Chen Q, Yan C, Hu Y, Jiang W, Tasci E, Zgela TC, Sproull M, Mackey M, Shankavaram U, Meerzaman D, Camphausen K. Krauze AV, et al. Among authors: sproull m. Front Oncol. 2023 Aug 10;13:1127645. doi: 10.3389/fonc.2023.1127645. eCollection 2023. Front Oncol. 2023. PMID: 37637066 Free PMC article.
52 results